Clinical trial
A Multi-site, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of Trehalose-reformulated Peru-15 (Choleragarde)Vaccine Given Simultaneously With Measles Vaccine in Healthy Indian and Bangladeshi Infants
NCT00624975 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-site, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of Trehalose-reformulated Peru-15 (Choleragarde)Vaccine Given Simultaneously With Measles Vaccine in Healthy Indian and Bangladeshi Infants
- Lead sponsor
- International Vaccine Institute
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2008
- Completion date
- July 31, 2012
- Enrollment
- 74 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.